BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34077453)

  • 1. Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease.
    Smith SCL; Banbury C; Zardo D; Cannatelli R; Nardone OM; Shivaji UN; Ghosh S; Oppenheimer PG; Iacucci M
    PLoS One; 2021; 16(6):e0252210. PubMed ID: 34077453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal Healing in Clinical Practice: A Single-Center Pediatric IBD Experience.
    Santha SL; Shankar PR; Pan A; Schoen B; Kugathasan S; Sauer CG
    Inflamm Bowel Dis; 2017 Aug; 23(8):1447-1453. PubMed ID: 28644180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
    Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
    Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
    World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseases.
    Roblin X; Marotte H; Rinaudo M; Del Tedesco E; Moreau A; Phelip JM; Genin C; Peyrin-Biroulet L; Paul S
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):80-84.e2. PubMed ID: 23891927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?
    Boon GJ; Day AS; Mulder CJ; Gearry RB
    World J Gastroenterol; 2015 Oct; 21(40):11469-80. PubMed ID: 26523111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Confocal Laser Endomicroscopy-Based Score for In Vivo Assessment of Mucosal Healing in Ulcerative Colitis Patients.
    Hundorfean G; Chiriac MT; Mihai S; Hartmann A; Mudter J; Neurath MF
    Inflamm Bowel Dis; 2017 Dec; 24(1):35-44. PubMed ID: 29272480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring.
    Nardone OM; Shivaji UN; Ferruzza V; Ghosh S; Iacucci M
    Inflamm Bowel Dis; 2020 May; 26(6):961-969. PubMed ID: 31587036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate and predictors of mucosal healing in patients with inflammatory bowel disease treated with anti-TNF-alpha antibodies.
    Beigel F; Deml M; Schnitzler F; Breiteneicher S; Göke B; Ochsenkühn T; Brand S
    PLoS One; 2014; 9(6):e99293. PubMed ID: 24932476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Azathioprine induce endoscopic and histologic healing in pediatric inflammatory bowel disease? A prospective, observational study.
    Giugliano FP; Strisciuglio C; Martinelli M; Andreozzi M; Cenni S; Campione S; D'Armiento M; Staiano A; Miele E
    Dig Liver Dis; 2018 Mar; 50(3):240-246. PubMed ID: 29174208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of Earlier Anti-TNF Treatment on IBD Disease Complications?
    Nuij V; Fuhler GM; Edel AJ; Ouwendijk RJ; Rijk MC; Beukers R; Quispel R; van Tilburg AJ; Tang TJ; Smalbraak H; Bruin KF; Lindenburg F; Peyrin-Biroulet L; van der Woude CJ;
    J Crohns Colitis; 2015 Nov; 9(11):997-1003. PubMed ID: 26223842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of mucosal healing for the management of IBD.
    Pineton de Chambrun G; Peyrin-Biroulet L; Lémann M; Colombel JF
    Nat Rev Gastroenterol Hepatol; 2010 Jan; 7(1):15-29. PubMed ID: 19949430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal and Histologic Healing in Children With Inflammatory Bowel Disease Treated With Antitumor Necrosis Factor-Alpha.
    Scarallo L; Alvisi P; Bolasco G; Di Toma M; Lanari M; Cangiari A; Paci M; Naldini S; Renzo S; Barp J; De Masi S; Lionetti P
    J Pediatr Gastroenterol Nutr; 2021 May; 72(5):728-735. PubMed ID: 33399329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective study.
    Paul S; Del Tedesco E; Marotte H; Rinaudo-Gaujous M; Moreau A; Phelip JM; Genin C; Peyrin-Biroulet L; Roblin X
    Inflamm Bowel Dis; 2013 Nov; 19(12):2568-76. PubMed ID: 24013361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide.
    Lazzerini M; Villanacci V; Pellegrin MC; Martelossi S; Magazzù G; Pellegrino S; Lucanto MC; Barabino A; Calvi A; Arrigo S; Lionetti P; Fontana M; Zuin G; Maggiore G; Bramuzzo M; Maschio M; Salemme M; Manenti S; Lorenzi L; Decorti G; Montico M; Ventura A
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1382-1389.e1. PubMed ID: 28286192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress markers in intestinal mucosa of Tunisian inflammatory bowel disease patients.
    Bouzid D; Gargouri B; Mansour RB; Amouri A; Tahri N; Lassoued S; Masmoudi H
    Saudi J Gastroenterol; 2013; 19(3):131-5. PubMed ID: 23680711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease.
    Al-Bawardy B; Ramos GP; Willrich MAV; Jenkins SM; Park SH; Aniwan S; Schoenoff SA; Bruining DH; Papadakis KA; Raffals L; Tremaine WJ; Loftus EV
    Inflamm Bowel Dis; 2019 Feb; 25(3):580-586. PubMed ID: 30165638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.